𧬠ICD-10 CM E11.40 β Type 2 Diabetes Mellitus with Diabetic Neuropathy, Unspecified
Billable Code Confirmed
ICD-10 CM E11.40 is a valid, billable 5-character ICD-10-CM code for FY2026. All five characters are present:
E11(category) +.4(neurological complications) +0(unspecified neuropathy). No 7th character is required.
Non-Billable Parent Codes β Never Submit These
- β
E11β 3-character header β missing complication specification- β
E11.4β 4-character header β missing specific neurological complicationAlways submit E11.40 (or a more specific sibling code) when type 2 diabetes with neuropathy is documented.
Clinical Context: "Unspecified" Neuropathy vs. Specific
ICD-10 CM E11.40 indicates the patient has nerve damage caused by their diabetes, but the exact type of neuropathy (e.g., polyneuropathy, mononeuropathy, autonomic) is unspecified in the documentation. If the provider specifically documents βdiabetic polyneuropathy,β a more specific code (E11.42) is strongly preferred over E11.40.
Code Classification
ICD-10-CM Diagnosis Code β Fields for wRVU, assistant payable, and global period are not applicable.
π Code Description
ICD-10 CM E11.40 classifies Type 2 diabetes mellitus with unspecified diabetic neuropathy. Diabetic neuropathy is a type of nerve damage that can occur if you have diabetes. High blood sugar (glucose) can injure nerves throughout the body.
This code is used when the physician documents that the patient has both Type 2 diabetes and neuropathy, but does not specify the neuropathy further (such as polyneuropathy, mononeuropathy, or autonomic neuropathy).
Under ICD-10-CM Official Guidelines (Section I.A.15), the word βwithβ or βinβ in a code title or index should be interpreted to mean βassociated withβ or βdue to.β The classification presumes a causal relationship between diabetes and neuropathy. Therefore, if a provider documents βType 2 Diabetesβ and βNeuropathyβ in the patientβs chart, they should be linked as E11.40, even if the provider doesnβt explicitly write βdiabetic neuropathy,β unless the provider specifically states the neuropathy is due to another cause (e.g., chemotherapy-induced).
π³ Code Tree / Hierarchy
E08-E13 Diabetes mellitus
β
βββ E11 Type 2 diabetes mellitus β Non-billable
β
βββ E11.4 Type 2 diabetes mellitus with neurological complications β Non-billable
β β
β βββ E11.40 Type 2 diabetes mellitus with diabetic neuropathy, unspecified β THIS CODE β
Billable
β βββ E11.41 Type 2 diabetes mellitus with diabetic mononeuropathy β
Billable
β βββ E11.42 Type 2 diabetes mellitus with diabetic polyneuropathy β
Billable
β βββ E11.43 Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy β
Billable
β βββ E11.44 Type 2 diabetes mellitus with diabetic amyotrophy β
Billable
β βββ E11.49 Type 2 diabetes mellitus with other diabetic neurological complication β
Billable
β
βββ E11.5 Type 2 diabetes mellitus with circulatory complications
βββ E11.6 Type 2 diabetes mellitus with other specified complications
Upgrade Specificity When Possible
ICD-10 CM E11.40 should only be assigned when the type of neuropathy is genuinely unspecified. Providers frequently diagnose βdiabetic polyneuropathyβ (DPN) because it is the most common presentation (stocking-glove pattern). If βpolyneuropathyβ is documented, upgrade the code to E11.42. A CDI query is appropriate to clarify the type of neuropathy if the patient has had nerve conduction studies or a detailed podiatric exam.
β Includes
The following clinical terms and scenarios map to E11.40:
- Type 2 diabetes mellitus with neuropathy NOS
- Patient has a history of type 2 diabetes and is diagnosed with neuropathy (due to the βwithβ guideline presumption)
- Diabetic nerve damage NOS
β Excludes
Excludes 1 β Cannot Be Coded Simultaneously with E11.40
| Code | Description | Note |
|---|---|---|
| E10.40 | Type 1 diabetes with neuropathy | Mutually exclusive β A patient cannot have Type 1 and Type 2 diabetes simultaneously as the underlying etiology. |
| E09.40 | Drug or chemical induced diabetes with neuropathy | Mutually exclusive β Indicates the diabetes was caused by a drug (e.g., chronic steroid use), not standard Type 2. |
π Clinical Overview
The βWithβ Guideline β A Critical Coding Rule
The ICD-10-CM guideline regarding the term βwithβ applies heavily to diabetes. Conditions listed under βwithβ in the Alphabetic Index for Diabetes (such as neuropathy, nephropathy, angiopathy) are presumed to be causally related.
- Documentation Example: Assessment states: β1. Type 2 Diabetes. 2. Neuropathy.β
- Coding Action: Code E11.40. The coder does not need the provider to explicitly state βdiabetic neuropathy.β The linkage is assumed by the classification system unless the provider documents an alternative cause for the neuropathy (e.g., alcoholic neuropathy).
Pathophysiology
Diabetic neuropathy is caused by prolonged exposure to high blood glucose, which damages the delicate nerve fibers and the microvascular blood vessels (vasa nervorum) that supply them with oxygen and nutrients.
Peripheral neuropathy is the most common form, typically starting in the longest nerves (feet and legs) and progressing proximally. Autonomic neuropathy affects the nerves controlling internal organs, leading to issues like gastroparesis, resting tachycardia, or neurogenic bladder.
Clinical Presentation
Patients with unspecified diabetic neuropathy typically present with:
- Numbness, reduced ability to feel pain or temperature changes (loss of protective sensation/LOPS)
- Tingling or burning sensations (paresthesia)
- Sharp, stabbing pain, usually worse at night
- Muscle weakness
- Loss of reflexes
- High risk for foot ulcers due to undetected trauma
Documentation Requirements
For accurate assignment of E11.40, physician documentation should include:
- Type of Diabetes β Type 1 vs. Type 2 (defaults to Type 2 if unspecified).
- Presence of Neuropathy β Explicit documentation of neuropathy, peripheral neuropathy, or nerve damage.
- Absence of alternative etiologies β If the neuropathy is due to something else (e.g., B12 deficiency), it must be clearly linked to that cause to override the diabetes presumption.
π° HCC Risk Adjustment (CMS-HCC v28)
| Field | Detail |
|---|---|
| CMS-HCC Model Version | v28 (2024-2025 Implementation) |
| HCC Assignment | HCC 18 (Diabetes with Chronic Complications) |
| RAF Coefficient | ~0.302 (Community Non-Dual Aged - varies by specific demographic) |
| RxHCC Assignment | RxHCC 31 |
Risk Adjustment Impact
ICD-10 CM E11.40 maps to HCC 18 (Diabetes with Chronic Complications), which carries a higher risk weight than diabetes without complications (HCC 19). Failing to link neuropathy to diabetes when the βwithβ guideline applies results in lost risk adjustment severity. Always capture this relationship when documented.
π₯ MS-DRG Assignment
MDC 21 β Endocrine, Nutritional and Metabolic Diseases
| DRG | Title | Est. Relative Weight* |
|---|---|---|
| DRG 637 | Diabetes with MCC | ~1.60 |
| DRG 638 | Diabetes with CC | ~0.85 |
| DRG 639 | Diabetes without CC/MCC | ~0.60 |
*Approximate. Verify against IPPS FY2026 Final Rule tables.
π Related ICD-10-CM Codes
Upgrade Codes β Specific Neuropathy
| Code | Description |
|---|---|
| E11.41 | Type 2 diabetes mellitus with diabetic mononeuropathy |
| E11.42 | Type 2 diabetes mellitus with diabetic polyneuropathy (Most common specific code) |
| E11.43 | Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E11.44 | Type 2 diabetes mellitus with diabetic amyotrophy |
Associated Complications (Code Additionally)
| Code | Description |
|---|---|
| E11.51 | Type 2 diabetes with diabetic peripheral angiopathy without gangrene (often coexists) |
| E11.621 | Type 2 diabetes with foot ulcer (requires additional code for the ulcer site L97.-) |
| Z79.4 | Long term (current) use of insulin |
| Z79.84 | Long term (current) use of oral hypoglycemic drugs |
π οΈ Commonly Associated CPT Codes (Outpatient/Physician)
| CPT Code | Description | Clinical Application |
|---|---|---|
| 99214 | Office or other outpatient visit, established patient, mod MDM | Routine management of complicated diabetes with neuropathy |
| 95905 | Motor and/or sensory nerve conduction, using preconfigured array | Diagnostic testing to confirm severity of peripheral neuropathy |
| 95907 | Nerve conduction studies; 1-2 studies | Diagnostic NCS testing |
| 11042 | Debridement, subcutaneous tissue; first 20 sq cm | Wound care for diabetic foot ulcers caused by loss of protective sensation |
NCCI & Coverage Considerations
Routine Foot Care Exclusions
Medicare generally does not cover routine foot care (e.g., cutting nails, trimming calluses). However, there is a specific exception for patients with systemic conditions resulting in severe circulatory embarrassment or areas of diminished sensation (like diabetic neuropathy). When billing routine foot care CPT codes (e.g., 11720, 11721), E11.40 or E11.42 is often required alongside specific Class Findings modifiers (Q7, Q8, Q9) to prove medical necessity.
π Coding Scenarios and Examples
Scenario 1 β Primary Care Visit, Linking Presumed
Clinical Vignette: A 65-year-old male presents for a diabetes follow-up. Assessment & Plan:
- Type 2 Diabetes Mellitus - A1C is 7.5%. Continue Metformin.
- Neuropathy - Patient complains of tingling in both feet. Started on Gabapentin.
- Hypertension - Stable on Lisinopril.
ICD-10-CM:
- E11.40 β Type 2 diabetes mellitus with diabetic neuropathy, unspecified (Linked via the βwithβ guideline)
- I10 β Essential (primary) hypertension
- Z79.84 β Long term (current) use of oral hypoglycemic drugs (For Metformin)
The "With" Guideline in Action
Even though the physician listed them as #1 and #2 separately and did not explicitly write βdiabetic neuropathy,β the ICD-10 guidelines mandate linking them under E11.40 because diabetes and neuropathy are presumed causally related in the alphabetic index.
Scenario 2 β Diabetic Polyneuropathy Documented
Clinical Vignette: A 70-year-old female presents to neurology with severe burning pain in her feet. The neurologist documents βDiabetic peripheral polyneuropathy in stocking-glove distribution.β
ICD-10-CM:
- E11.42 β Type 2 diabetes mellitus with diabetic polyneuropathy
Upgrade from E11.40
Do not use E11.40 here. The provider explicitly specified βpolyneuropathy,β allowing the coder to upgrade to the more specific code E11.42.
Scenario 3 β Diabetic Neuropathy with Foot Ulcer (Inpatient)
Clinical Vignette: A 68-year-old male with a history of Type 2 diabetes and peripheral neuropathy is admitted with a non-healing ulcer on his left heel. Exam shows full-thickness skin loss with subcutaneous fat visible. The physician documents βDiabetic foot ulcer left heel due to underlying diabetic neuropathy.β
Principal Diagnosis:
- E11.621 β Type 2 diabetes mellitus with foot ulcer
Additional Diagnoses:
- L97.422 β Non-pressure chronic ulcer of left heel and midfoot with fat layer exposed (Mandatory secondary code for the ulcer)
- E11.40 β Type 2 diabetes mellitus with diabetic neuropathy, unspecified (Captures the underlying neurological complication)
Multiple Coding Rule
When a patient has multiple diabetic complications (e.g., an ulcer AND neuropathy), you must code all applicable complication codes. You code the ulcer complication (E11.621 + L97.422) AND the neuropathy complication (E11.40).
β οΈ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| β | Do not ignore the βWithβ guideline β If a patient has diabetes and neuropathy, link them as E11.40 unless another cause is explicitly stated. |
| β | Do not default to E11.40 if polyneuropathy is documented β Upgrade to E11.42 if the provider specifies βpolyneuropathy.β |
| β | Do not use for Type 1 Diabetes β Ensure the patient is actually Type 2. If Type 1, use E10.40. |
| β | Code additional complications β If the patient also has diabetic chronic kidney disease or retinopathy, assign those specific E11.- codes as well. |
| β | Code long-term medication use β Always add Z79.4 for insulin or Z79.84 for oral hypoglycemics if the patient is taking them for their Type 2 diabetes. |
π Sources
- CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026. Section I.A.15 (The βWithβ Guideline); Chapter 4 (Endocrine, Nutritional, and Metabolic Diseases).
- CMS. 2025-2026 Medicare Advantage Risk Adjustment β CMS-HCC Model v28 ICD-10-CM Mappings. 3. CMS. IPPS Final Rule FY2026 β MS-DRG Definitions Manual v43. MDC 21 logic tables.
- AMA. CPT Professional Edition 2026. Medicine subsection (Nerve Conduction Tests).
Crystal's Coder Hub